Serotonin and Dopamine Transporter (SERT, DAT) Availabilities as Assessed by b-CIT and SPECT, and Neurophysiological Measures of Central Serotonergic Activity in Patients With Depression Under Treatment With Escitalopram
Sponsor study identifier
Secondary identifiers
interventional
30
1 country
1
Study Start
June 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2009
Actual (reported)Study Completion
December 2009
Actual (reported)Aim of this project is to investigate the effects of escitalopram on monoamine transporter (SERT, DAT) availabilities as assessed by b-CIT and SPECT, and on neurophysiological parameters such as the loudness dependence of auditory evoked potentials (LDAEP) in patients with depression.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2005
Date type not reportedThis date has not been verified as actual or estimated.
September 1, 2005
Actual (reported)September 5, 2005
Actual (reported)December 2009
Actual (reported)December 2009
Actual (reported)changes in β-CIT/neurophysiological measurements from baseline to week 4
two assessments, at baseline and week 4
β-CIT-SPECT scans and EEG recordings, two assessments each
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Depts. of Psychiatry and Nuclear Medicine, Ludwig-Maximilians-University of Munich
Munich, D-80336, Germany
Oliver Pogarell, MD
Dept. of Psychiatry, University of Munich
30 participants (actual enrollment reported by the registry).
First Submitted
September 1, 2005
First Posted
September 5, 2005
Study Start
June 2005
Date type not reportedThis date has not been verified as actual or estimated.
DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome
Contact the study team to confirm eligibility.
Primary Completion
December 2009
Actual (reported)Study Completion
December 2009
Actual (reported)Last Updated
June 2, 2010
Record last verified: 2010-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: